Potential for chemoprevention

Cancer
|December 1, 1982
PubMed

Insights

Chemopreventive agents, both natural and synthetic, show promise in preventing or reversing cancer stages. Human trials are underway, with retinoids and ascorbic acid demonstrating effectiveness in specific conditions.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Chemopreventive agents are compounds used to prevent, inhibit, or reverse carcinogenesis.
  • These agents can be natural (e.g., vitamins, indoles, flavones) or synthetic (e.g., retinoids, antioxidants).

Purpose of the Study:

  • To review the mechanisms and efficacy of chemopreventive agents in cancer prevention.
  • To highlight findings from in vitro, in vivo, and early human trials.

Main Methods:

  • Review of scientific literature on chemopreventive agents.
  • Analysis of in vitro and in vivo tumor model studies.
  • Examination of data from ongoing human clinical trials.

Main Results:

  • Chemopreventive agents exhibit diverse mechanisms, including immune stimulation, gene suppression, carcinogen detoxification, and blocking oxidative DNA damage.
  • Retinoids show effectiveness against proliferative skin tumors.
  • Ascorbic acid demonstrated a modest suppressive effect on rectal adenomas in polyposis patients.
  • 13-cis-retinoic acid shows potential in modifying oral leukoplakia.

Conclusions:

  • Chemopreventive agents offer a promising strategy for cancer control.
  • Further human trials are crucial to establish the clinical utility of these agents.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...